Biographical Information: Sheri Ann Strite
Evidence-based Practice Resources & Services for Value & Patient-centered Care
Help For Health Care Decision-makers & Help to Achieve Clinical Quality Improvement

Sheri_Strite

Sheri Ann Strite
Principal &
Managing Partner


Delfini Group EBM DolphinDelfini Group EBM Dolphin

 

Sheri Ann Strite
Sheri Strite is an expert in applied evidence- and value-based clinical improvement strategies and has over a decade of practical and academic experience as a practitioner, facilitator and trainer in this area.  Ms. Strite has expertise in a wide range of topics in evidence-based health care such as clinical quality improvement methods and processes, evidence-based committee management and operations, assessment of medical technologies such as drugs and devices, formulary decision-making, health care economic evaluations, performance measurement, decision support and patient-centered strategies.  Her work as a principle with Delfini Group has resulted in many innovations in methods and tools. 

Ms. Strite is best known for the development of the highly regarded tool-based critical appraisal training program: Using Medical Literature—A Simplified Approach, the program scores for which average 4.8 out of 5.0, and she has trained thousands of physicians, clinical pharmacists and other healthcare professionals in these methods. 

Ms. Strite co-authored a series of articles on the "Evidence-based Organization" for publication in The American College of Physician Executive's Journal of Medical Management. She is a contributing author to numerous publications and to the textbook, Evidence-based Pharmacotherapy, and is an associate editor for DynaMed and guest editor for the California Pharmacist Journal.

She has considerable expertise in clinical guideline development, medical technology assessment and in pharmacy and therapeutics (P&T) committee work and service, helping transform others into highly-functioning committees.  She has consulted with major groups to help them streamline their processes, restructure their methods, increase their skills and improve the overall functioning of their EBM work groups including decision-making criteria and processes.

Ms. Strite has developed programs and presentations for and consulted with government entities, academia, major health plans, healthcare systems, specialty societies, industry and others. 

She has participated in development of numerous systematic reviews, medical technology assessments, monographs, clinical guidelines, evaluative criteria and more on a wide variety of topics. 

While at the University California, San Diego (2002-2005), Ms. Strite was an Associate Director for Program Development and was responsible for teaching evidence-based methods to medical and pharmacy students, residents and community physicians and participated in faculty development. She served as a member of the UCSD Family Medicine Research Leaders. Her work at UCSD also included serving as advisor and faculty for the Family Medicine Research Fellowship program, advisor for the UCSD Family Practice EBM Journal Club, and faculty and curriculum developer for the School of Medicine and for disciplinary programs for referral by the California State Medical Board. Ms. Strite is a past member of the Society for Teachers of Family Medicine (2003-2006).

Prior to her work with Delfini and UCSD, Ms. Strite was with Group Health Cooperative in Seattle, Washington (1977-2002). There she held various positions in health services and clinical research management and evidence-based clinical improvement and medical education.

Strite Publications

  1. Stuart ME, Strite SA.  Systematic Review: Comparative Safety of Six Biologic Agents For The Treatment of Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis.  June 2011. http://www.delfini.org/index_DelfiniShowcase.htm#DMARDS.  Accessed 08/16/2011.
  2. Chien M, Yee J, Stern C.  Arbiter 6 Halts Trial.  [evidence-based medicine review]. California Pharmacist 2011. Vol. LVIII, No.2 Spring 2011: 54-57. (Stuart ME, Strite SA, peer reviewers and guest eds.)
  3. Strite SA, Stuart ME. BMJ Rapid Response: Attrition Bias Caution: Non-differential Loss Between Groups Can Threaten Validity. BMJ 2011; http://www.bmj.com/content/341/bmj.c7053.extract/reply#bmj_el_247314 [Link]
  4. Strite SA, Stuart ME. Letter to the Editor: How to Evaluate Medical Science. The Atlantic. January/February 2011.
  5. Strite SA, Stuart ME. Importance of Blinding in Randomized Trials: To the Editor. JAMA. 2010 Nov 17;304(19):2127-8.
  6. Pazirandeh M, Stern C. Treatment for Type 2 Diabetes Mellitus and Stable Ischemic Heart Disease. [evidence-based medicine review]. California Pharmacist 2010. Vol. LVII, No. 1. Winter 2010: 46-49. (Stuart ME, Strite SA, peer reviewers and guest eds.) [PDF] [Note: PDF says Winter 2009, but this is a misprint; should read Winter 2010.]
  7. Stuart ME, Strite SA. Washington State Health Care Technology Assessment: Breast MRI In Diagnosis and Treatment of Cancer in Women at High Risk. Systematic Review. July 23, 2010.
  8. Liu T, Stern C. The Platelet Inhibition and Patient Outcomes (PLATO) Trial. [evidence-based medicine review]. California Pharmacist 2010. Vol. LVII, No. 2. Spring 2010: 46-48. (Stuart ME, Strite SA, peer reviewers and guest eds.)[PDF]
  9. Juneja R, Stuart ME, Strite SA. Intensive Insulin Therapy for The Treatment of Hyperglycemia in Critically Ill Adults: A Qualitative Systematic Review and Critical Appraisal of the Evidence. Selected for Poster Presentation at the American Diabetes Association's 70th Scientific Sessions, June 25-29, 2010. [Link]
  10. Strite SA, Stuart ME. Getting Started with Critical Appraisal of Medical Literature: It Is Easier Than You Think. California Pharmacist 2009. Vol. LVI, No.4. Fall 2009: 52-55. Online
  11. Chan M, Fong P, Stern C. Chloramphenicol Wound Infection Prophylaxis. [evidence-based medicine review]. California Pharmacist 2009. Vol. LVI, No.4. Fall 2009: 56-58. (Stuart ME, Strite SA, peer reviewers and guest eds.) Online
  12. Strite SA, Stuart ME. BMJ Rapid Response: Re: Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement— response to David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman for the PRISMA Group
    Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535 Online
  13. Stuart ME, Strite SA. BMJ Rapid Response: Re: The role of specialists, information systems and an evidence-based approach in managing the health of populations with chronic illness— response to Lee, B. Practice. BMJ 2009;339:b2395 Online
  14. Salman G, Tran K, Chan S, Stern C. Jupiter Trial. [evidence-based medicine review]. California Pharmacist 2009. Vol. LVI, No.2. Spring 2009: 54-55. (Stuart ME, Strite SA, peer reviewers and guest eds.) [PDF]
  15. Carrillo M, Preechakul R, Stern C. A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Pregabalin in the Treatment of Patients with Fibromyalgia. [evidence-based medicine review]. California Pharmacist 2009. Lol. LVI, No.1. Winter 2009: 52-53. (Stuart ME, Strite SA, peer reviewers and guest eds.) [PDF]
  16. Patel S, Strite SA, Stuart ME, Stern C. ADVANCE Trial. [evidence-based medicine review]. California Pharmacist 2008. Vol LV, No. 4. Fall 2008: 58-61. [PDF]
  17. Stuart ME, Strite SA. Washington State Health Care Technology Assessment: Evidence Report Arthroscopic Surgery of the Knee for Osteoarthritis. Systematic Review. July 18, [Link]
  18. Strite SA, Stuart ME. An Introduction to Systematic Reviews: The Lifeblood of Medical Decision-making. California Pharmacist 2008. Vol LV, No. 3. Summer 2008: 52-56. [PDF]
  19. Ericksen J, Strite SA, Stuart ME, Stern C. CATIE Trial Review of Phases 1 and 2. [evidence-based medicine review]. California Pharmacist 2008. Vol LV, No. 3. Summer 2008: 52-56. [PDF]
  20. Strite SA, Stuart ME, Urban S. Process steps and suggestions for creating drug monographs and drug class reviews in an evidence-based formulary system. Formulary. April 2008;43:135–145.
  21. Nguyen K, Equinozio C, Stern C. Esprit Trial [evidence-based medicine review]. California Pharmacist 2008. Vol LV, No 1. Winter 2008: 30-31. (Stuart ME, Strite SA, peer reviewers and guest eds.) Online
  22. Chiquette E, Posey LM. Evidence-based Pharmacotherapy. American Pharmacists Association. APhA Publications; 1 edition (January 15, 2007). ISBN-10: 1582120684; ISBN-13: 978-1582120683
    (Strite SA, Stuart ME, contributing authors. Chapter 7. Applying Evidence-Based Pharmacotherapy to Formulary Decisions)
  23. Delfini White Paper — Missing Data: Consideration. October 2007, updated February 2008. [WORD] & [PDF]
  24. Stuart M, Strite SA. 2005 Jan 30. Pitfalls to Performance Measurement. Modern Healthcare. http://www.delfini.org/Showcase_Publication_PerformanceMeasures.htm#mhc_article. Originally published 2006 Jan 23. Accessed 2006 Jan 30. See also related white papers. Delfini White Paper: Evidence-based Performance Measurement: Validity Issues & Avoiding Important Pitfalls — Long Version: Recommended [PDF] and Short Version [PDF]
  25. Stuart ME, Strite SA. Radical Prostatectomy versus Watchful Waiting. [Letter to the Editor Re: Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical Prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352:1977-84.] N Engl J Med 2005; 353; 12: 1298
  26. Stuart ME, Strite SA. British Medical Journal Rapid Response: Steroids Not Proven in Bell’s Palsy—The Legacy of Bad Science — response to Piercy J. Primary Care: Bell's Palsy. BMJ 2005; 330:1374 (11 June) Online
  27. Strite S, Stuart ME. “Closing Quality and Value Gaps. (Part 3)” The Physician Executive, Journal of Medical Management. May/June 2005; 58-61. PDF & Series Online
  28. Strite S, Stuart ME. “Finding Gaps in Quality and Value. (Part 2)” The Physician Executive, Journal of Medical Management. Mar/Apr 2005; 50-54. PDF
  29. Stuart ME, Strite SA. Bell’s Palsy. [Letter to the Editor Re: Gilden D. Bell’s Palsy. N Engl J Med 2004;351:1323-31.] N Engl J Med 2005; 352; 4: 416-418.
  30. Strite S, Stuart ME. “What is an Evidence-Based, Value-Based Health Care System? (Part 1)” The Physician Executive, Journal of Medical Management. Jan/Feb 2005; 50-54. PDF
  31. Strite SA, Stuart ME. “Response to Proposal for Strength of the Evidence Taxonomy (SORT)” Letter to the Editors. American Family Physician. December 15, 2004; Vol 70. No 12; 2268. Online
  32. Strite SA, Stuart ME. “Response to ‘Making Evidence-Based Medicine Doable in Everyday Practice: Finding the evidence you need is getting easier than you ever thought possible,” and ‘A Simple Method for Evaluating the Clinical Literature: The "PP-ICONS" approach will help you separate the clinical wheat from the chaff in mere minutes.” Letter to the Editor. Family Practice Management. October 2004; Vol 11. No 9; 14. Online
  33. Stuart ME, Strite SA. British Medical Journal Rapid Response: Corticosteriods are Not Proven for Treatment of Bell's Palsy — response to Holland JN, Weiner GM, Recent developments in Bell's palsy. BMJ 2004;329:553-557 (4 September) Online
  34. Peer-reviewer for DynaMed ® DynaMed® is a registered trademark of and published by Dynamic Medical Information Systems, LLC – Irritable Bowel Syndrome (1/2004) and Rotator Cuff Tear (2/2004)
  35. Crittendon R, Stuart ME, Strite SA. “Promoting Better Quality and Decreasing Costs in Health Care.” White paper presented at 2003 Annual Health Care Conference – We Can’t Wait: Improving Washington’s Health. Rainier Institute. White Paper. (9/2003) [PDF] This policy proposal was aimed at establishing an evidence-based technology review committee and set of work processes for evaluating and determining evidence basis for new medications and technologies being considered by the purchasers of health care in the State of Washington.
  36. Strite SA, “Clinical Practice Guidelines are Not Created Equal: A Guide to Choosing Clinical Practice Guidelines,” GHC Clinical Forum, Group Health Cooperative (Fall 1998).
  37. Strite SA, Stuart ME, Handley M, Braddick M. “Choosing Clinical Practice Guidelines,” White paper from Group Health Cooperative (1997).
  38. Strite SA. “Sir Gawain and the Green Knight: To Behead or Not to Behead – That is a Question,” Philological Quarterly 70 (1991) U of Iowa.
  39. Kakar F, Weiss NS, Strite SA. “Thiazide Use and the Risk of Cholecystectomy in Women,” American Journal of Epidemiology 1986 Sep: 1243):428-33.
  40. Kakar F, Weiss NS, Strite SA. “Non-contraceptive estrogen use and the risk of gallstone disease in women.” Am J Public Health. 1988 May;78(5):564-6.


About Us
........
Use of our website implies agreement to our Notices.

Home
What's New
Intro Links
Services
Resources
Success Stories
Notices
About Us
About Our Work
Testimonials
Other
Site Navigator
Contact Us

Site Search
.......
delfini.org
Delfini Group EBM Dolphin

Also creators of
medicalleaders.org
........

Quick Navigator to Selected Resources:

Delfini Flier

EBM Delfini Guiding Lights

Delfini SERVICES
We offer a wide range of supportive services with the ultimate goal of increasing health care organizations’ and clinicians’ abilities to provide high quality, evidence-based care and to improve medical decision-making for organizations, leaders, teams, clinicians and patients.

Delfini About Our Work Delfini Group EBM DolphinDelfini Group EBM Dolphin

Resources at —

Return to Top

© 2002-2012 Delfini Group, LLC. All Rights Reserved Worldwide.
Dolphin photo for Dolphins Poolside attributed to RevolverOcelo. Delfini Boat thanks to Dr. Bat Shunatona.
Thanks too to contributors to Openclipart.org and Wiki Media.

Use of this website implies your agreement to our Notices.

EBM Solutions for Evidence-based Health Care Quality